Operating Lease, Right-of-Use Asset of Tvardi Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tvardi Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Tvardi Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $163,000.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Tvardi Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $163,000 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $181,000 -$3,465,000 -95% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $0 -$3,826,000 -100% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $216,000 -$4,648,000 -96% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $3,646,000 +$2,854,000 +360% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $3,826,000 +$2,651,000 +226% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $4,864,000 +$3,313,000 +214% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $7,108,000 +$5,190,000 +271% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $792,000 -$1,486,000 -65% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $1,175,000 -$1,454,000 -55% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $1,551,000 -$1,422,000 -48% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 $1,918,000 -$1,392,000 -42% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $2,278,000 -$1,363,000 -37% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $2,629,000 -$1,334,000 -34% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $2,973,000 -$1,306,000 -31% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 $3,310,000 +$656,000 +25% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $3,641,000 +$816,000 +29% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $3,963,000 +$1,087,000 +38% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $4,279,000 +$1,243,000 +41% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $2,654,000 -$538,000 -17% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $2,825,000 -$519,000 -16% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $2,876,000 -$616,000 -18% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $3,036,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $3,192,000 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $3,344,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $3,492,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.